Soluble peptidoglycan from Staphylococcus aureus is a murine B-lymphocyte mitogen.
AUTOR(ES)
Babu, U M
RESUMO
Soluble peptidoglycan from Staphylococcus aureus has been shown to be capable of causing murine B lymphocytes from the spleen to proliferate and to secrete immunoglobulins in both an in vitro and an in vivo assay. The optimal concentration in vitro was between 33 and 100 micrograms/ml. A 3-day incubation with soluble peptidoglycan was more stimulatory than was a 1- or 2-day incubation. Removal of most of the T lymphocytes with anti-theta serum did not result in any significant change in the mitogenic activity of soluble peptidoglycan on the remaining B cells.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=264400Documentos Relacionados
- A murine model for B-lymphocyte somatic cell gene therapy.
- Evidence for B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice.
- In vivo polyclonal B-lymphocyte activation elicited by murine viruses.
- Demonstration of a B-lymphocyte mitogen produced by the Lyme disease pathogen, Borrelia burgdorferi.
- Synergistic effects of antigen and soluble T-cell factors in B-lymphocyte activation.
